- Obtains ISO 14001 (Environmental Management System) and ISO 50001 (Energy Management System)
- Recognized for steady practices and dedication to enhancing sustainability administration
INCHEON, Korea, Sept. 14, 2022 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. at this time introduced that it has attained two ISO certifications: ISO 140001 (Environmental Management System) and ISO 50001 (Energy Management System) from Lloyd’s Register Quality Assurance (LRQA), reflecting the corporate’s ongoing practices and dedication to changing into a sustainable firm.
“We are delighted to obtain the globally recognized ISO certifications as this underscores that our environmental and energy management systems are meeting stringent global standards,” mentioned Christopher Hansung Ko, President and Chief Executive Officer at Samsung Bioepis. “We will continue to enhance and strengthen our sustainability management across our business activities.”
Samsung Bioepis is engaged in varied environmental administration actions at every step of worth chain from packaging to delivery merchandise with eco-friendly supplies.
As a part of its power administration practices, the corporate’s headquarters are geared up with particular coated glass for its exterior to scale back warmth loss in addition to energy-efficient lighting units and pumping methods. The firm has additionally put in place a administration system for waste, air pollution and unsafe chemical substances which might be produced at its worksites.
Furthermore, Samsung Bioepis selects and companions with those that have attained ISO certification akin to ISO 14001 for environmental administration system and ISO 45001 for occupational well being and administration system to make sure sustainable practices are adopted all through its provide chain.
With the aim of changing into a socially accountable and sustainable firm, Samsung Bioepis revealed its first sustainability report in 2021, highlighting the corporate’s Environment, Social and Governance (ESG) efficiency. The report particulars the corporate’s efforts throughout the three pillars of sustainability and dedication to creating long-term ESG initiatives that are navigated by a devoted ESG staff throughout the firm. Detailed data on sustainability could be discovered at Samsung Bioepis’ web site: https://bit.ly/3ee4jI0.
About Samsung Bioepis Co., Ltd.
Established in 2012, Samsung Bioepis is a biopharmaceutical firm dedicated to realizing healthcare that’s accessible to everybody. Through improvements in product improvement and a agency dedication to high quality, Samsung Bioepis goals to turn out to be the world’s main biopharmaceutical firm. Samsung Bioepis continues to advance a broad pipeline of biologic candidates that cowl a spectrum of therapeutic areas, together with immunology, oncology, ophthalmology, hematology, endocrinology and gastroenterology. For extra data, please go to: www.samsungbioepis.com and observe us on social media – Twitter, LinkedIn.
